NCT02323178
- Conditions
- Blood Platelet Disorders, Bone Marrow Diseases, CMML, +14 more
- Locations
-
- CHU d'Amiens Amiens, France
- CHU d'Angers Angers, France
- CH Victor Dupouy Argenteuil, France
- Hôpital Avicenne Bobigny, France
Clinical trial condition
Myelodysplastic-Myeloproliferative Diseases
Explore clinical trials studying Myelodysplastic-Myeloproliferative Diseases. Study availability and eligibility vary by location and protocol.
384 public trials
62 recruiting studies
Myelodysplastic-Myeloproliferative Diseases trial results
Completed
Pilot Study of Leuprolide to Improve Immune Function After Allogeneic Bone Marrow Transplantation
NCT01338987
- Conditions
- Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Bone Marrow Diseases, +25 more
- Locations
-
- Childrens National Medical Center Washington D.C., District of Columbia, United States
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
- University of Oklahoma Oklahoma City, Oklahoma, United States
NCT00489203
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +207 more
- Locations
-
- Hackensack University Medical Center Hackensack, New Jersey, United States
- Fred Hutchinson Cancer Research Center Seattle, Washington, United States
NCT01445080
- Conditions
- Blast Crisis, Blastic Phase, Bone Marrow Diseases, +33 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Children's Hospital of Orange County Orange, California, United States
- Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
- Children's National Medical Center Washington D.C., District of Columbia, United States
NCT01613976
- Conditions
- Acute Myeloid Leukemia (AML), Bone Marrow Diseases, Chronic Disease, +15 more
- Locations
-
- Novartis Investigative Site Nagoya, Aichi-ken, Japan
- Novartis Investigative Site Nagoya, Aichi-ken, Japan
- Novartis Investigative Site Kobe, Hyōgo, Japan
- Novartis Investigative Site Sendai, Miyagi, Japan
NCT02092324
- Conditions
- Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Bone Marrow Diseases, Chronic Disease, +14 more
- Locations
-
- Stanford Cancer Institute Palo Alto Palo Alto, California, United States
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
- Washington University School of Medicine St Louis, Missouri, United States
- OHSU Knight Cancer Institute Portland, Oregon, United States
NCT02458235
- Conditions
- Acute Lymphoid Leukemia, Acute Myelogenous Leukemia, Bone Marrow Diseases, +18 more
- Locations
-
- University of California San Francisco San Francisco, California, United States
NCT00809250
- Conditions
- Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +14 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT00309842
- Conditions
- Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Anemia, +66 more
- Locations
-
- Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States
- Fred Hutchinson Cancer Research Center Seattle, Washington, United States
- Conditions
- Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +14 more
- Locations
-
- Georgia Health Sciences University Dept. of MCG Augusta, Georgia, United States
- Goshen Center for Cancer Care IU Cancer Center Indianapolis, Indiana, United States
- University of Kansas Hospital and Medical Center SC - Univ KS Kansas City, Kansas, United States
- Dana Farber Cancer Institute Beth Israel Deaconess Med Ctr Boston, Massachusetts, United States